Arvinas, Inc

(NASDAQ:ARVN)

Latest On Arvinas, Inc (ARVN):

Date/Time Type Description Signal Details
2023-05-05 11:16 ESTNewsArvinas GAAP EPS of -$1.54, revenue of $32.5MN/A
2023-03-30 01:06 ESTNewsArvinas: PROTAC Platform Shows Promise In Clinical Trials For Oncology IndicationsN/A
2023-02-23 12:01 ESTNewsArvinas GAAP EPS of -$1.56 misses by $0.39, revenue of $38M beats by $2.68MN/A
2023-01-20 15:29 ESTNewsBayer, Oerth Bio team up to develop sustainable crop protection productsN/A
2023-01-10 01:57 ESTNewsArvinas falls 17% after early-stage data for Pfizer-partnered tumor therapyN/A
2023-01-04 02:47 ESTNewsApellis, Arvinas lower as Wells Fargo downgrades in 2023 biotech previewN/A
2022-12-05 05:02 ESTNewsArvinas: Promising Science, Poor DataN/A
2022-11-22 16:27 ESTNewsPfizer, Arvinas breast cancer therapy hits 38% clinical benefit in Phase 2 trialN/A
2022-11-09 02:35 ESTNewsArvinas GAAP EPS of -$1.24 misses by $0.12, revenue of $30.3M misses by $4.42MN/A
2022-09-09 18:28 ESTNewsArvinas initiated Overweight at Barclays on attractive therapeutic platformN/A
2022-08-25 09:07 ESTNewsArvinas: Pioneer In Protein Degradation Sports Unappealing Risk/Reward ProfileN/A
2022-08-19 12:16 ESTNewsArvinas a buy at Piper Sandler following failure of Sanofi breast cancer treatmentN/A
2022-08-04 23:37 ESTNewsArvinas GAAP EPS of $1.32 beats by $2.38, revenue of $31.3M beats by $7.59MN/A
2022-05-23 13:56 ESTNewsArvinas: Still Holding, Just Not Buying MoreN/A
2022-05-10 02:23 ESTNewsArvinas stock down 17% after Wedbush downgrades to neutralN/A
2022-05-05 22:17 ESTNewsArvinas GAAP EPS of -$1.20 misses by $0.28, revenue of $24.2M misses by $1.31MN/A
2022-03-01 03:13 ESTNewsArvinas GAAP EPS of -$1.00 misses by $0.21, revenue of $26.3M beats by $11.22MN/A
2022-02-10 23:30 ESTNewsArvinas, Kymera started as biotech overweights at Wells FargoN/A
2022-02-07 18:10 ESTNewsArvinas: One Of The Most Interesting Science-Heavy Emerging BiopharmaN/A
2022-01-20 00:57 ESTNewsArvinas, Arrowhead win Buy ratings as Goldman Sachs starts coverage on platform biotechsN/A
2021-12-10 10:39 ESTNewsPfizer, Arvinas' ARV-471 shows encouraging clinical benefit rate in breast cancer patientsN/A
2021-12-08 02:35 ESTNewsArvinas up following Cowen outperform initiation; sees promise for breast cancer therapyN/A
2021-11-19 07:46 ESTNewsArvinas: 2022 Is Full Of Catalysts For This Protein Degrader PioneerN/A
2021-11-04 04:18 ESTNewsArvinas reports Q3 resultsN/A
2021-10-21 00:48 ESTNewsRadius Health price target raised on Wall Street after trial win for breast cancer drugN/A
2021-10-08 03:38 ESTNewsArvinas (ARVN) Investor Presentation - SlideshowN/A
2021-08-09 23:29 ESTNewsArvinas and Insilico Medicine ink R&D collaboration agreementN/A
2021-08-05 22:24 ESTNewsArvinas EPS misses by $0.17, beats on revenueN/A
2021-07-31 23:15 ESTNewsArvinas: Tremendous Value Increase With Pfizer Mega-Deal, High PotentialN/A
2021-07-22 19:19 ESTNewsArvinas, Pfizer team up to develop ARV-471 in breast cancerN/A
2021-07-22 19:18 ESTNewsArvinas price target raised to a Street-high at Truist on Pfizer dealN/A
2021-07-20 20:02 ESTNewsConnecting The Dots: Are Pfizer And Arvinas At Work On A COVID Cure?N/A
2021-05-04 15:10 ESTNewsArvinas EPS misses by $0.04, beats on revenueN/A
2021-03-30 21:25 ESTNewsAscendis downgraded at Oppenheimer, Aytu initiated at overweight at Cantor and more in today's analyst actionN/A
2021-03-30 21:24 ESTNews'Data-rich 2H21' could send Arvinas shares 140% higher, Cantor saysN/A
2021-03-19 13:39 ESTNewsArvina (ARVN) Investor Presentation - SlideshowN/A
2021-03-12 20:41 ESTNewsMerck and Pfizer among top picks to lead 2021 biopharma M&A activity: Goldman SachsN/A
2021-03-11 11:08 ESTAnalyst RatingThe Analyst Target Price has decreased from $103 to $102.5.Neutral
2021-03-03 15:07 ESTFinancialsCompany financials have been released.Neutral
2021-03-02 11:08 ESTAnalyst RatingThe Analyst Target Price has decreased from $103.8 to $103.Neutral
2021-03-02 11:08 ESTEarnings EstimateAn EPS average of -$3.94 is estimated for the 2022 year.Sell
2021-03-02 11:08 ESTEarnings EstimateAn EPS average of -$0.84 is estimated for the quarter ending on June 30, 2021.Buy
2021-02-24 11:07 ESTAnalyst RatingThe Analyst Target Price has increased from $96.4 to $103.8.Buy
2021-01-20 07:09 ESTAnalyst RatingThe Analyst Target Price has increased from $94.4 to $96.4.Buy
2021-01-05 11:12 ESTAnalyst RatingThe Analyst Target Price has decreased from $96.18 to $94.4.Neutral
2021-01-03 00:21 ESTNewsArvinas: Leading In Cutting Edge Protein Degrader DevelopmentN/A
2020-12-22 11:08 ESTAnalyst RatingThe Analyst Target Price has increased from $92.64 to $96.18.Buy
2020-12-16 11:09 ESTAnalyst RatingThe Analyst Target Price has increased from $80.36 to $92.64.Buy
2020-12-16 02:19 ESTNewsArvinas continues the upward trend after dual upgradesN/A
2020-12-16 02:18 ESTNewsArvinas prices $400M stock offeringN/A

About Arvinas, Inc (ARVN):

Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates are ARV-110, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor (AR) protein for the treatment of men with metastatic castration-resistant prostate cancer; and ARV-471, a PROTAC protein degrader targeting the estrogen receptor protein for the treatment of patients with metastatic ER positive/HER2 negative breast cancer. The company has collaborations with Pfizer Inc., Genentech, Inc., F. Hoffman-La Roche Ltd., and Bayer AG. Arvinas, Inc. was incorporated in 2013 and is based in New Haven, Connecticut.

ARVN Quotes by TradingView

See Advanced Chart

General

  • Name Arvinas, Inc
  • Symbol ARVN
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 179
  • Fiscal Year EndDecember
  • IPO Date2018-09-27
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryPharmaceuticals
  • Gic SubIndustryPharmaceuticals
  • Web URLhttp://www.arvinas.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 131.11
  • Price/Book (Most Recent Quarter) 5.5
  • Enterprise Value Revenue 130.68
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$3.37
  • Next Year EPS Estimate -$3.96
  • Next Quarter EPS Estimate -$0.73
  • Operating Margin -573%
  • Return on Assets -15%
  • Return on Equity -27%
  • Revenue 21.8 million
  • Earnings Per Share -$7.16
  • Revenue Per Share $0.55
  • Gross Profit 21.8 million
  • Quarterly Earnings Growth -54.7%
View More

Highlights

  • Market Capitalization 3.26 billion
  • EBITDA -64270736
  • PE Ratio -5.55
  • Analyst Target Price $102.5
  • Book Value Per Share $13.26
View More

Share Statistics

  • Shares Outstanding 48.46 million
  • Shares Float 41.19 million
  • % Held by Insiders 1204%
  • % Held by Institutions 76.78%
  • Shares Short 1.78 million
  • Shares Short Prior Month 1.64 million
  • Short Ratio 3.96
  • Short % of Float 4%
  • Short % of Shares Outstanding 4%
View More

Technicals

  • Beta 2.18
  • 52 Week High $92.77
  • 52 Week Low $19.68
  • 50 Day Moving Average 76.84
  • 200 Day Moving Average 49.59
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Arvinas, Inc (ARVN) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Arvinas, Inc (ARVN) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-01$N/A-$0.99-$0.73-35.82%
2020-09-302020-11-05$7.6 million-$0.79-$0.66-19.75%
2020-06-302020-08-04$N/A-$0.65-$0.59-10.96%
2020-03-312020-04-28$6.24 million-$0.56-$0.595.08%
2019-12-312020-03-16$4.89 million-$0.56-$0.53-4.81%
2019-09-302019-11-04$30.05 million-$0.54-$0.52-3.89%
2019-06-302019-08-05$4.02 million-$0.55-$0.43-28.69%
2019-03-312019-05-08$4.02 million-$0.46-$0.472.09%
2018-12-312019-03-26$3.44 million-$0.52-$0.6013.51%
2018-09-302018-11-14$3.38 million-$0.57-$0.28-103.57%

Arvinas, Inc (ARVN) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date Dec 31 2020 Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019
Research Development N/A 30.01 million N/A 21.73 million 20.41 million
Income Before Tax N/A -30.82 million N/A -21.74 million -21.05 million
Selling General Administrative N/A 9.33 million N/A 7.93 million 7.27 million
Gross Profit N/A N/A N/A N/A 4.89 million
Ebit N/A -29.71 million N/A -20.94 million -22.79 million
Operating Income N/A -31.75 million N/A -23.41 million -22.79 million
Income Tax Expense N/A N/A N/A N/A N/A
Total Revenue N/A 7.6 million N/A 6.24 million 4.89 million
Cost of Revenue N/A N/A N/A N/A N/A
Total Other Income Expense Net N/A 144215 N/A 390009 1.74 million
Net Income From Continuing Operations N/A -30.82 million N/A -21.74 million -21.05 million
Net Income Applicable to Common Shares -41.55 million -30.82 million -25.23 million -21.74 million -21.05 million
Cash Flow:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Investments 59.28 million N/A 42.49 million N/A N/A
Change to Liabilities -3.12 million -6.11 million -4.12 million N/A N/A
Total Cash Flow from Investing Activities 59.28 million 5.61 million 42.49 million N/A N/A
Net Borrowings N/A N/A N/A N/A N/A
Total Cash Flow from Financial Activities 30.5 million N/A 1.35 million N/A N/A
Change to Operating Activities 4.41 million 860214 1.64 million N/A N/A
Change in Cash 67.4 million N/A 26.9 million N/A N/A
Total Cash from Operating Activities -22.38 million -21.4 million -16.95 million N/A N/A
Depreciation 1.09 million N/A 787373 N/A N/A
Other Cash Flow from Investing Activities N/A N/A N/A N/A N/A
Change to Inventory N/A N/A N/A N/A N/A
Change to Account Receivables -2.44 million N/A N/A N/A N/A
Other Cash Flow from Financing Activities -916704 N/A N/A N/A N/A
Change to Net Income 8.5 million 8.21 million 6.49 million N/A N/A
Capital Expenditures 1.41 million N/A 1.36 million N/A N/A
Balance Sheet:
Date Dec 31 2020 Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019
Total Liabailities N/A N/A N/A 70.74 million 74.96 million
Total Stockholder Equity N/A N/A N/A 211.71 million 226.69 million
Other Current Liabilities 22.15 million 21.36 million N/A N/A 19.98 million
Total Assets N/A N/A N/A 282.45 million 301.64 million
Common Stock 48455 40096 38825 38672 38461
Other Current Assets N/A N/A N/A N/A N/A
Retained Earnings -491.89 million -450.34 million -419.52 million -394.3 million -372.56 million
Other Liabilities 22.94 million 23.95 million 27.49 million 33.73 million 38.43 million
Other Assets 28777 28777 28777 28777 26757
Cash N/A N/A N/A 36.11 million 9.21 million
Total Current Liabilities 49.09 million 39.53 million N/A 33.17 million 32.81 million
Other Stockholder Equity 560796 1.08 million 1.66 million -602614 107576
Property, Plant & Equipment 14.25 million 13.94 million 12.97 million 12.23 million 10.73 million
Total Current Assets 703.09 million 257.98 million N/A 270.2 million 290.88 million
Long Term Investments N/A N/A N/A N/A N/A
Net Tangible Assets 642.26 million 205.12 million 197.78 million 211.71 million 226.69 million
Short Term Investments N/A N/A N/A 226.73 million 271.66 million
Long Term Debt N/A N/A N/A 2 million 2 million
Inventory N/A N/A N/A N/A N/A
Accounts Payable 7.12 million 5.09 million N/A 3.02 million 4.56 million

Arvinas, Inc (ARVN) Chart:

Arvinas, Inc (ARVN) News:

Below you will find a list of latest news for Arvinas, Inc (ARVN) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Arvinas, Inc (ARVN) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-06-202.53.2CALL0 0401.78TRUE00
2025-06-2052.05CALL62 16488105.17TRUE-0.29-0.12
2025-06-207.50.25CALL429 865572.53FALSE-0.25-0.5
2025-06-20100.05CALL50 1114106.14FALSE-0.05-0.5
2025-06-2012.50.05CALL0 425135.88FALSE00
2025-06-20150.02CALL0 363215.49FALSE00
2025-06-202.50.01PUT2 12219.19FALSE0.010
2025-06-2050.01PUT1 91180.5FALSE-0.04-0.8
2025-06-207.50.82PUT76 94687.05TRUE0.120.17
2025-06-20100PUT0 108157.49TRUE00
2025-06-2012.50PUT0 0252.65TRUE00
2025-06-20150PUT0 00TRUE00
2025-07-182.50CALL0 3244.47TRUE00
2025-07-1852.1CALL3 49675.77TRUE-0.18-0.08
2025-07-187.50.58CALL156 689178.16FALSE-0.17-0.23
2025-07-18100.15CALL3 1011285.81FALSE-0.08-0.35
2025-07-1812.50.05CALL0 1145168.8FALSE00
2025-07-18150.1CALL0 314159.11FALSE00
2025-07-1817.50.07CALL0 226175FALSE00
2025-07-18200CALL0 338223.63FALSE00
2025-07-1822.50CALL0 13239.12FALSE00
2025-07-18250CALL0 126252.57FALSE00
2025-07-18300CALL0 374240.41FALSE00
2025-07-18350CALL0 131293.34FALSE00
2025-07-18400CALL0 61284.04FALSE00
2025-07-182.50PUT0 200308.7FALSE00
2025-07-1850.1PUT0 165576.15FALSE00
2025-07-187.50.9PUT7 178078.75TRUE-0.25-0.22
2025-07-18102.9PUT0 132592.11TRUE00
2025-07-1812.50PUT0 534136.44TRUE00
2025-07-18150PUT0 430TRUE00
2025-07-1817.50PUT0 2263.4TRUE00
2025-07-18200PUT0 0283.94TRUE00
2025-07-1822.50PUT0 0239.08TRUE00
2025-07-18250PUT0 0284.25TRUE00
2025-07-18300PUT0 0323.28TRUE00
2025-07-18350PUT0 0357.46TRUE00
2025-07-18400PUT0 0324.45TRUE00
2025-10-172.54.8CALL0 10135.7TRUE00
2025-10-1752.63CALL0 3478.3TRUE00
2025-10-177.51.3CALL75 525272.31FALSE0.050.04
2025-10-17100.53CALL0 267571.86FALSE00
2025-10-1712.50.3CALL0 285475.52FALSE00
2025-10-17150.1CALL0 197878.81FALSE00
2025-10-1717.50.08CALL0 126119.46FALSE00
2025-10-17200CALL0 21130.04FALSE00
2025-10-1722.50CALL0 1136.74FALSE00
2025-10-17250CALL0 2144.49FALSE00
2025-10-17300CALL0 0157.45FALSE00
2025-10-17350CALL0 0168FALSE00
2025-10-17400CALL0 2176.87FALSE00
2025-10-172.50PUT0 28179.06FALSE00
2025-10-1750.41PUT0 14176.21FALSE00
2025-10-177.51.4PUT5 39168.32TRUE-0.13-0.09
2025-10-17103.7PUT0 54473.3TRUE00
2025-10-1712.56.25PUT0 2384.79TRUE00
2025-10-17150PUT0 77684.15TRUE00
2025-10-1717.50PUT0 0155.43TRUE00
2025-10-17200PUT0 0168.15TRUE00
2025-10-1722.50PUT0 0126.3TRUE00
2025-10-17250PUT0 0192.25TRUE00
2025-10-17300PUT0 0205.19TRUE00
2025-10-17350PUT0 0264.27TRUE00
2025-10-17400PUT0 0306.3TRUE00
2025-12-192.50CALL0 7144.04TRUE00
2025-12-1952.75CALL1 31885.27TRUE0.080.03
2025-12-197.51.46CALL0 129475.97FALSE00
2025-12-19100.65CALL0 544172.17FALSE00
2025-12-1912.50.36CALL0 145665.68FALSE00
2025-12-19150.2CALL0 506572.24FALSE00
2025-12-1917.50.35CALL0 51896.46FALSE00
2025-12-19200.1CALL0 42181.77FALSE00
2025-12-1922.50CALL0 62114.47FALSE00
2025-12-19250.2CALL0 104120.93FALSE00
2025-12-19300CALL0 134127.67FALSE00
2025-12-19350.1CALL1 260107.72FALSE0.10
2025-12-192.50PUT0 27129.09FALSE00
2025-12-1950.53PUT0 100975.24FALSE00
2025-12-197.52.1PUT0 75079.96TRUE00
2025-12-19103.8PUT0 55473.76TRUE00
2025-12-1912.56.2PUT0 1164.99TRUE00
2025-12-19158.75PUT0 983.99TRUE00
2025-12-1917.50PUT0 0137.73TRUE00
2025-12-19200PUT0 7146.05TRUE00
2025-12-1922.50PUT0 0127.39TRUE00
2025-12-19250PUT0 0158.15TRUE00
2025-12-19300PUT0 0136.55TRUE00
2025-12-19350PUT0 0142.5TRUE00
2026-01-162.55.3CALL0 489.74TRUE00
2026-01-1652.9CALL0 382.54TRUE00
2026-01-167.51.6CALL41 21478.87FALSE1.60
2026-01-16100.8CALL4 49172.06FALSE00
2026-01-1612.50.35CALL0 8266.16FALSE00
2026-01-162.50PUT0 0139.75FALSE00
2026-01-1650PUT0 082.69FALSE00
2026-01-167.51.7PUT0 1673.12TRUE00
2026-01-16100PUT0 069.9TRUE00
2026-01-1612.50PUT0 069.68TRUE00

Latest ARVN Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST16$36.97
Jun 13, 2022 7:59 PM EST106$36.93
Jun 13, 2022 7:59 PM EST2$36.98
Jun 13, 2022 7:59 PM EST21$36.92
Jun 13, 2022 7:59 PM EST36$36.92

Arvinas, Inc (ARVN) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1655759/000120919120039888/0001209191-20-039888-index.htm
2019-10-07UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1655759/000000000019014356/0000000000-19-014356-index.htm
2019-10-07UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1655759/000000000019014357/0000000000-19-014357-index.htm
2020-10-13SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1655759/000031506620001801/0000315066-20-001801-index.htm
2018-10-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1655759/000089924318026069/0000899243-18-026069-index.htm
2018-10-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1655759/000089924318026071/0000899243-18-026071-index.htm
2018-10-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1655759/000089924318026072/0000899243-18-026072-index.htm
2018-10-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1655759/000089924318026073/0000899243-18-026073-index.htm
2018-10-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1655759/000089924318026075/0000899243-18-026075-index.htm
2018-10-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1655759/000089924318026076/0000899243-18-026076-index.htm
2018-10-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1655759/000089924318026078/0000899243-18-026078-index.htm
2018-10-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1655759/000089924318026089/0000899243-18-026089-index.htm
2019-01-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1655759/000089924319001732/0000899243-19-001732-index.htm
2019-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1655759/000089924319006227/0000899243-19-006227-index.htm
2019-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1655759/000089924319006233/0000899243-19-006233-index.htm
2019-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1655759/000089924319006234/0000899243-19-006234-index.htm
2019-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1655759/000089924319006237/0000899243-19-006237-index.htm
2019-04-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1655759/000089924319009401/0000899243-19-009401-index.htm
2019-04-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1655759/000089924319009575/0000899243-19-009575-index.htm
2019-05-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1655759/000089924319014874/0000899243-19-014874-index.htm
2019-05-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1655759/000089924319014876/0000899243-19-014876-index.htm
2019-05-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1655759/000089924319014878/0000899243-19-014878-index.htm
2019-05-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1655759/000089924319014879/0000899243-19-014879-index.htm
2019-05-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1655759/000089924319014881/0000899243-19-014881-index.htm
2019-05-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1655759/000089924319014885/0000899243-19-014885-index.htm
2019-05-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1655759/000089924319014888/0000899243-19-014888-index.htm
2019-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1655759/000089924319016634/0000899243-19-016634-index.htm
2019-07-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1655759/000089924319019621/0000899243-19-019621-index.htm
2019-07-263Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1655759/000089924319020448/0000899243-19-020448-index.htm
2019-07-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1655759/000089924319020450/0000899243-19-020450-index.htm
2019-07-313Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1655759/000089924319020679/0000899243-19-020679-index.htm
2019-07-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1655759/000089924319020681/0000899243-19-020681-index.htm
2019-07-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1655759/000089924319020690/0000899243-19-020690-index.htm
2019-11-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1655759/000089924319027280/0000899243-19-027280-index.htm
2020-07-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1655759/000089924320019796/0000899243-20-019796-index.htm
2020-10-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1655759/000089924320028308/0000899243-20-028308-index.htm
2018-10-10SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1655759/000094787118000811/0000947871-18-000811-index.htm
2018-10-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1655759/000110465918060328/0001104659-18-060328-index.htm
2019-02-13SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1655759/000110465919007931/0001104659-19-007931-index.htm
2019-04-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1655759/000110465919019024/0001104659-19-019024-index.htm
2019-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1655759/000110465919034661/0001104659-19-034661-index.htm
2019-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1655759/000110465919038785/0001104659-19-038785-index.htm
2019-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1655759/000110465919050625/0001104659-19-050625-index.htm
2019-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1655759/000110465919050626/0001104659-19-050626-index.htm
2019-09-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1655759/000110465919051601/0001104659-19-051601-index.htm
2020-02-06SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1655759/000110465920011472/0001104659-20-011472-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1655759/000110465920020291/0001104659-20-020291-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1655759/000110465920021900/0001104659-20-021900-index.htm
2018-10-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1655759/000114420418052316/0001144204-18-052316-index.htm
2019-02-13SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1655759/000114420419007248/0001144204-19-007248-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1655759/000114420419008309/0001144204-19-008309-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1655759/000117266120000919/0001172661-20-000919-index.htm
2018-10-10SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1655759/000119312518296880/0001193125-18-296880-index.htm
2019-01-24SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1655759/000119312519015652/0001193125-19-015652-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1655759/000119312519039707/0001193125-19-039707-index.htm
2019-03-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1655759/000119312519076853/0001193125-19-076853-index.htm
2019-04-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1655759/000119312519094647/0001193125-19-094647-index.htm
2019-04-12DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1655759/000119312519105281/0001193125-19-105281-index.htm
2019-04-12DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1655759/000119312519105286/0001193125-19-105286-index.htm
2019-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1655759/000119312519141625/0001193125-19-141625-index.htm
2019-05-10S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1655759/000119312519144337/0001193125-19-144337-index.htm
2019-05-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1655759/000119312519158416/0001193125-19-158416-index.htm
2019-06-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1655759/000119312519164618/0001193125-19-164618-index.htm
2019-07-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1655759/000119312519194831/0001193125-19-194831-index.htm
2019-07-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1655759/000119312519202599/0001193125-19-202599-index.htm
2019-08-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1655759/000119312519212963/0001193125-19-212963-index.htm
2019-10-01S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1655759/000119312519259952/0001193125-19-259952-index.htm
2019-10-01S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1655759/000119312519259965/0001193125-19-259965-index.htm
2019-10-08CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1655759/000119312519264281/0001193125-19-264281-index.htm
2019-10-08CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1655759/000119312519264284/0001193125-19-264284-index.htm
2019-10-11424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1655759/000119312519266263/0001193125-19-266263-index.htm
2019-10-18424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1655759/000119312519270133/0001193125-19-270133-index.htm
2019-10-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1655759/000119312519272040/0001193125-19-272040-index.htm
2019-11-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1655759/000119312519283519/0001193125-19-283519-index.htm
2019-11-06424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1655759/000119312519286089/0001193125-19-286089-index.htm
2019-11-07424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1655759/000119312519287274/0001193125-19-287274-index.htm
2019-11-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1655759/000119312519289908/0001193125-19-289908-index.htm
2019-11-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1655759/000119312519297586/0001193125-19-297586-index.htm
2020-02-06SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1655759/000119312520026242/0001193125-20-026242-index.htm
2020-02-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1655759/000119312520026873/0001193125-20-026873-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1655759/000119312520038541/0001193125-20-038541-index.htm
2020-03-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1655759/000119312520073986/0001193125-20-073986-index.htm
2020-03-16S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1655759/000119312520074994/0001193125-20-074994-index.htm
2020-04-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1655759/000119312520123266/0001193125-20-123266-index.htm
2020-05-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1655759/000119312520141786/0001193125-20-141786-index.htm
2020-05-20DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1655759/000119312520147449/0001193125-20-147449-index.htm
2020-05-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1655759/000119312520154927/0001193125-20-154927-index.htm
2020-06-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1655759/000119312520160809/0001193125-20-160809-index.htm
2020-06-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1655759/000119312520162331/0001193125-20-162331-index.htm
2020-06-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1655759/000119312520166729/0001193125-20-166729-index.htm
2020-06-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1655759/000119312520184135/0001193125-20-184135-index.htm
2020-08-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1655759/000119312520209370/0001193125-20-209370-index.htm
2020-10-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1655759/000119312520268956/0001193125-20-268956-index.htm
2020-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1655759/000119312520286232/0001193125-20-286232-index.htm
2019-08-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1655759/000120919119045324/0001209191-19-045324-index.htm
2019-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1655759/000120919119051780/0001209191-19-051780-index.htm
2019-11-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1655759/000120919119055696/0001209191-19-055696-index.htm
2019-11-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1655759/000120919119056788/0001209191-19-056788-index.htm
2019-11-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1655759/000120919119057640/0001209191-19-057640-index.htm
2019-11-223Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1655759/000120919119057797/0001209191-19-057797-index.htm
2019-11-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1655759/000120919119057808/0001209191-19-057808-index.htm
2019-12-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1655759/000120919119061326/0001209191-19-061326-index.htm
2020-01-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1655759/000120919120005638/0001209191-20-005638-index.htm
2020-02-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1655759/000120919120008425/0001209191-20-008425-index.htm
2020-03-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1655759/000120919120014636/0001209191-20-014636-index.htm
2020-03-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1655759/000120919120014640/0001209191-20-014640-index.htm
2020-03-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1655759/000120919120014678/0001209191-20-014678-index.htm
2020-03-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1655759/000120919120014684/0001209191-20-014684-index.htm
2020-03-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1655759/000120919120020503/0001209191-20-020503-index.htm
2020-03-234/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1655759/000120919120020729/0001209191-20-020729-index.htm
2020-03-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1655759/000120919120020734/0001209191-20-020734-index.htm
2020-03-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1655759/000120919120020795/0001209191-20-020795-index.htm
2020-03-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1655759/000120919120020799/0001209191-20-020799-index.htm
2020-03-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1655759/000120919120020801/0001209191-20-020801-index.htm
2020-03-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1655759/000120919120020803/0001209191-20-020803-index.htm
2020-03-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1655759/000120919120021041/0001209191-20-021041-index.htm
2020-03-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1655759/000120919120021125/0001209191-20-021125-index.htm
2020-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1655759/000120919120029413/0001209191-20-029413-index.htm
2020-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1655759/000120919120029414/0001209191-20-029414-index.htm
2020-05-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1655759/000120919120032172/0001209191-20-032172-index.htm
2020-05-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1655759/000120919120032410/0001209191-20-032410-index.htm
2020-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1655759/000120919120034583/0001209191-20-034583-index.htm
2020-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1655759/000120919120034584/0001209191-20-034584-index.htm
2020-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1655759/000120919120034585/0001209191-20-034585-index.htm
2020-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1655759/000120919120034586/0001209191-20-034586-index.htm
2020-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1655759/000120919120034587/0001209191-20-034587-index.htm
2020-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1655759/000120919120034588/0001209191-20-034588-index.htm
2020-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1655759/000120919120034589/0001209191-20-034589-index.htm
2020-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1655759/000120919120034590/0001209191-20-034590-index.htm
2020-06-123Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1655759/000120919120036357/0001209191-20-036357-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1655759/000120919120036363/0001209191-20-036363-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1655759/000120919120037980/0001209191-20-037980-index.htm
2020-07-013Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1655759/000120919120039884/0001209191-20-039884-index.htm
2020-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1655759/000120919120039888/0001209191-20-039888-index.htm
2020-08-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1655759/000120919120047315/0001209191-20-047315-index.htm
2018-10-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1655759/000140508618000206/0001405086-18-000206-index.htm
2018-11-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1655759/000156459018029393/0001564590-18-029393-index.htm
2019-03-2610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1655759/000156459019009357/0001564590-19-009357-index.htm
2019-05-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1655759/000156459019017454/0001564590-19-017454-index.htm
2019-08-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1655759/000156459019028501/0001564590-19-028501-index.htm
2019-11-0410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1655759/000156459019039841/0001564590-19-039841-index.htm
2020-03-1610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1655759/000156459020011004/0001564590-20-011004-index.htm
2020-04-21DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1655759/000156459020017721/0001564590-20-017721-index.htm
2020-04-21DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1655759/000156459020017724/0001564590-20-017724-index.htm
2020-04-2810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1655759/000156459020019266/0001564590-20-019266-index.htm
2020-08-0410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1655759/000156459020036168/0001564590-20-036168-index.htm
2020-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1655759/000156459020051413/0001564590-20-051413-index.htm
2019-07-19DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1655759/000165575919000001/0001655759-19-000001-index.htm
2019-10-10EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1655759/999999999519002291/9999999995-19-002291-index.htm
2019-10-10EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1655759/999999999519002292/9999999995-19-002292-index.htm
2019-05-03CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1655759/999999999719003840/9999999997-19-003840-index.htm

Arvinas, Inc (ARVN) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Arvinas, Inc (ARVN). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 1204%
Institutional Ownership: 7678%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-06-275AM VENTURES III, L.P.10% Share HolderSell11,306.0021.75245,905.50100,207.00https://www.sec.gov/Archives/edgar/data/1655759/000110465919038785/0001104659-19-038785-index.htm
2019-06-075AM VENTURES III, L.P.10% Share HolderSell4,774.0019.6593,809.10111,513.00https://www.sec.gov/Archives/edgar/data/1655759/000110465919034661/0001104659-19-034661-index.htm
2019-03-285AM VENTURES III, L.P.10% Share HolderSell9,073.0014.16128,451.00116,287.00https://www.sec.gov/Archives/edgar/data/1655759/000110465919019024/0001104659-19-019024-index.htm
2020-02-07Sean A CassidyChief Financial OfficerSell30.0054.101,623.00149,115.00https://www.sec.gov/Archives/edgar/data/1655759/000120919120008425/0001209191-20-008425-index.htm
2020-02-07Sean A CassidyChief Financial OfficerSell1,302.0052.8668,823.72149,145.00https://www.sec.gov/Archives/edgar/data/1655759/000120919120008425/0001209191-20-008425-index.htm
2020-05-12Sean A CassidyChief Financial OfficerSell10,000.0060.00600,000.00150,422.00https://www.sec.gov/Archives/edgar/data/1655759/000120919120029413/0001209191-20-029413-index.htm
2020-02-07Sean A CassidyChief Financial OfficerSell1,880.0052.3098,324.00150,447.00https://www.sec.gov/Archives/edgar/data/1655759/000120919120008425/0001209191-20-008425-index.htm
2020-05-13Sean A CassidyChief Financial OfficerBuy1,356.0016.0021,696.00151,778.00https://www.sec.gov/Archives/edgar/data/1655759/000120919120029414/0001209191-20-029414-index.htm
2020-02-07Sean A CassidyChief Financial OfficerSell2,190.0050.97111,624.30152,327.00https://www.sec.gov/Archives/edgar/data/1655759/000120919120008425/0001209191-20-008425-index.htm
2020-03-19Sean A CassidyChief Financial OfficerSell1,514.0037.6156,941.54152,392.00https://www.sec.gov/Archives/edgar/data/1655759/000120919120020795/0001209191-20-020795-index.htm
2020-03-19Sean A CassidyChief Financial OfficerBuy4,791.00153,906.00https://www.sec.gov/Archives/edgar/data/1655759/000120919120020795/0001209191-20-020795-index.htm
2020-02-07Sean A CassidyChief Financial OfficerSell4,598.0049.97229,762.06154,517.00https://www.sec.gov/Archives/edgar/data/1655759/000120919120008425/0001209191-20-008425-index.htm
2019-11-19Sean A CassidyChief Financial OfficerSell10,000.0032.00320,000.00159,115.00https://www.sec.gov/Archives/edgar/data/1655759/000120919119057640/0001209191-19-057640-index.htm
2019-07-29Sean A CassidyChief Financial OfficerSell60.0028.031,681.80162,865.00https://www.sec.gov/Archives/edgar/data/1655759/000089924319020690/0000899243-19-020690-index.htm
2019-07-29Sean A CassidyChief Financial OfficerSell1,108.0027.0429,960.32162,925.00https://www.sec.gov/Archives/edgar/data/1655759/000089924319020690/0000899243-19-020690-index.htm
2019-07-29Sean A CassidyChief Financial OfficerSell10,777.0026.13281,603.01164,033.00https://www.sec.gov/Archives/edgar/data/1655759/000089924319020690/0000899243-19-020690-index.htm
2019-08-07Sean A CassidyChief Financial OfficerBuy6,250.0016.00100,000.00169,115.00https://www.sec.gov/Archives/edgar/data/1655759/000120919119045324/0001209191-19-045324-index.htm
2018-10-01Sean A CassidyChief Financial OfficerBuy1,600.0016.0025,600.00169,465.00https://www.sec.gov/Archives/edgar/data/1655759/000089924318026071/0000899243-18-026071-index.htm
2018-10-01Liam RatcliffeDirectorBuy625,000.0016.0010,000,000.001,908,048.00https://www.sec.gov/Archives/edgar/data/1655759/000089924318026073/0000899243-18-026073-index.htm
2020-08-14Ronald PeckChief Medical OfficerSell1,256.0027.4634,489.762,754.00https://www.sec.gov/Archives/edgar/data/1655759/000120919120047315/0001209191-20-047315-index.htm
2020-03-24Briggs MorrisonDirectorBuy2,500.0038.1895,450.0029,520.00https://www.sec.gov/Archives/edgar/data/1655759/000120919120021125/0001209191-20-021125-index.htm
2018-10-01Jakob LovenDirectorBuy312,500.0016.005,000,000.00312,500.00https://www.sec.gov/Archives/edgar/data/1655759/000089924318026069/0000899243-18-026069-index.htm
2018-10-01RA CAPITAL MANAGEMENT, LLCInsiderBuy1,000,000.0016.0016,000,000.003,138,412.00https://www.sec.gov/Archives/edgar/data/1655759/000114420418052316/0001144204-18-052316-index.htm
2018-10-01Edward Moore Jr. KennedyDirectorBuy21,000.0016.00336,000.0034,385.00https://www.sec.gov/Archives/edgar/data/1655759/000089924318026076/0000899243-18-026076-index.htm
2019-06-285AM VENTURES III, L.P.10% Share HolderSell350,955.0022.027,728,029.103,537,261.00https://www.sec.gov/Archives/edgar/data/1655759/000110465919038785/0001104659-19-038785-index.htm
2018-10-01Liam RatcliffeDirectorBuy375,000.0016.006,000,000.00375,000.00https://www.sec.gov/Archives/edgar/data/1655759/000089924318026073/0000899243-18-026073-index.htm
2019-06-275AM VENTURES III, L.P.10% Share HolderSell438,694.0021.759,541,594.503,888,216.00https://www.sec.gov/Archives/edgar/data/1655759/000110465919038785/0001104659-19-038785-index.htm
2020-08-14Ronald PeckChief Medical OfficerBuy4,010.004,010.00https://www.sec.gov/Archives/edgar/data/1655759/000120919120047315/0001209191-20-047315-index.htm
2019-06-075AM VENTURES III, L.P.10% Share HolderSell185,226.0019.653,639,690.904,326,910.00https://www.sec.gov/Archives/edgar/data/1655759/000110465919034661/0001104659-19-034661-index.htm
2019-03-285AM VENTURES III, L.P.10% Share HolderSell352,056.0014.164,984,232.824,512,136.00https://www.sec.gov/Archives/edgar/data/1655759/000110465919019024/0001104659-19-019024-index.htm
2018-10-01TIMOTHY M SHANNONDirectorBuy4,000.0016.0064,000.0055,398.00https://www.sec.gov/Archives/edgar/data/1655759/000089924318026078/0000899243-18-026078-index.htm
2019-11-13Ian TaylorChief Scientific OfficerSell10,000.0028.00280,000.0055,496.00https://www.sec.gov/Archives/edgar/data/1655759/000120919119056788/0001209191-19-056788-index.htm
2019-03-28TIMOTHY M SHANNONDirectorBuy3,500.0014.6951,409.7558,898.00https://www.sec.gov/Archives/edgar/data/1655759/000089924319009401/0000899243-19-009401-index.htm
2020-03-18Bradley Albert MargusDirectorSell40,000.0037.461,498,400.0059,463.00https://www.sec.gov/Archives/edgar/data/1655759/000120919120020503/0001209191-20-020503-index.htm
2020-03-20TIMOTHY M SHANNONDirectorBuy2,500.0040.00100,000.0061,623.00https://www.sec.gov/Archives/edgar/data/1655759/000120919120020734/0001209191-20-020734-index.htm
2020-05-26Liam RatcliffeDirectorBuy6,500.0022.06143,390.006,500.00https://www.sec.gov/Archives/edgar/data/1655759/000120919120032410/0001209191-20-032410-index.htm
2019-11-05Ian TaylorChief Scientific OfficerSell1,000.0024.0524,050.0065,496.00https://www.sec.gov/Archives/edgar/data/1655759/000120919119055696/0001209191-19-055696-index.htm
2019-11-05Ian TaylorChief Scientific OfficerSell9,000.0023.55211,950.0066,496.00https://www.sec.gov/Archives/edgar/data/1655759/000120919119055696/0001209191-19-055696-index.htm
2019-11-12Liam RatcliffeDirectorBuy680,000.0022.0014,960,000.00680,000.00https://www.sec.gov/Archives/edgar/data/1655759/000089924319027280/0000899243-19-027280-index.htm
2020-01-28Ian TaylorChief Scientific OfficerBuy13,042.0016.00208,672.0068,538.00https://www.sec.gov/Archives/edgar/data/1655759/000120919120005638/0001209191-20-005638-index.htm
2020-03-19Ian TaylorChief Scientific OfficerSell826.0037.6131,065.8670,398.00https://www.sec.gov/Archives/edgar/data/1655759/000120919120020799/0001209191-20-020799-index.htm
2020-03-19Ian TaylorChief Scientific OfficerBuy2,686.0071,224.00https://www.sec.gov/Archives/edgar/data/1655759/000120919120020799/0001209191-20-020799-index.htm
2020-05-26TIMOTHY M SHANNONDirectorBuy12,923.0022.06285,081.3874,546.00https://www.sec.gov/Archives/edgar/data/1655759/000120919120032172/0001209191-20-032172-index.htm
2019-09-30Ian TaylorChief Scientific OfficerSell1,300.0022.5429,302.0075,496.00https://www.sec.gov/Archives/edgar/data/1655759/000120919119051780/0001209191-19-051780-index.htm
2019-09-30Ian TaylorChief Scientific OfficerSell8,700.0021.76189,312.0076,796.00https://www.sec.gov/Archives/edgar/data/1655759/000120919119051780/0001209191-19-051780-index.htm
2018-10-01John G HoustonPresident and CEOBuy30,000.0016.00480,000.00772,860.00https://www.sec.gov/Archives/edgar/data/1655759/000089924318026075/0000899243-18-026075-index.htm
2020-06-02TIMOTHY M SHANNONDirectorBuy3,000.0032.3096,900.0077,546.00https://www.sec.gov/Archives/edgar/data/1655759/000120919120034590/0001209191-20-034590-index.htm
2020-06-17TIMOTHY M SHANNONDirectorBuy2,000.0030.2660,519.8079,546.00https://www.sec.gov/Archives/edgar/data/1655759/000120919120037980/0001209191-20-037980-index.htm
2019-12-17John G HoustonPresident and CEOBuy12,500.0016.00200,000.00797,844.00https://www.sec.gov/Archives/edgar/data/1655759/000120919119061326/0001209191-19-061326-index.htm
2020-03-19John G HoustonPresident and CEOSell5,405.0037.61203,282.05809,950.00https://www.sec.gov/Archives/edgar/data/1655759/000120919120020801/0001209191-20-020801-index.htm
2020-03-19John G HoustonPresident and CEOBuy17,511.00815,355.00https://www.sec.gov/Archives/edgar/data/1655759/000120919120020801/0001209191-20-020801-index.htm
2020-03-23John G HoustonPresident and CEOBuy6,250.0016.00100,000.00816,200.00https://www.sec.gov/Archives/edgar/data/1655759/000120919120021041/0001209191-20-021041-index.htm
2019-03-29Ian TaylorChief Scientific OfficerBuy1,000.0014.6614,660.3085,496.00https://www.sec.gov/Archives/edgar/data/1655759/000089924319009575/0000899243-19-009575-index.htm
2019-06-285AM VENTURES III, L.P.10% Share HolderSell9,045.0022.02199,170.9091,162.00https://www.sec.gov/Archives/edgar/data/1655759/000110465919038785/0001104659-19-038785-index.htm
2018-10-01Bradley Albert MargusDirectorBuy40,000.0016.00640,000.0099,463.00https://www.sec.gov/Archives/edgar/data/1655759/000089924318026072/0000899243-18-026072-index.htm